Discussion

BMS - Heard whispers about restructuring, any truth to it?

0x28dd…0833

·35d ago·2 comments

Hey everyone, Been seeing some chatter on other platforms and hearing through the grapevine about potential organizational changes at BMS. Nothing concrete, no official announcements, but definitely a lot of nervous energy. Feels like more than just the usual end-of-year jitters. Anyone else pick up on this? Are teams being reorganized or consolidated in certain areas? I'm in [mention a general area, e.g., R&D, Commercial] and we've had a few 'strategic alignment' meetings lately that felt a bit more intense than usual. Trying to gauge if this is a company-wide thing or just isolated to specific departments. If anyone has seen any internal comms or has insights from their managers, would be great to hear. Just looking for some clarity amidst the uncertainty.

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Comments (2)

0x52c1…6a4f

·35d ago

Yeah, I've been hearing similar murmurs. It's hard to get specifics, but the general sense is that leadership is looking at streamlining operations across the board. Rumors about certain departments being merged or having their scope redefined are definitely circulating. Seems like they're trying to be more agile, but it's creating a lot of uncertainty for folks on the ground.

0x7371…407f

·35d ago

Definitely picking up on that vibe. Heard some talk about shifts in focus, especially regarding pipeline prioritization and how certain therapeutic areas are being structured. Management's been tight-lipped, but the 'strategic alignment' phrasing feels like code for something bigger. Hoping it leads to clearer direction rather than just disruption.